Bringing Your Innovations to European Patients

 Contact

Team

IGES Pharma provides solutions for your market access challenges. We consider our broad experience as a toolbox at your service. Depending on your needs and specifications, tailored solutions are put together from one source, integrating expertise and experts from our subsidiaries in Europe as needed.
                                          

Acker

Janice Acker

Value & Access Strategy

Ansaripour

Dr. Amir Ansaripour

Health Economics & Outcomes Research

Bamberger

Dr. Manuela Bamberger

Value & Access Strategy

Ben Taieb

Adam Ben Taieb

Market Access UK

Bergemann

Eika Louisa Bergemann

HTA & Value Demonstration

Berkemeier

Fabian Berkemeier

Managing Director Pharma & Biotech

Braunschweig

Wiebke Braunschweig

Statistics & Biometrics

Brückel

Susanne Brückel

HTA & Value Demonstration

Daroszewska

Agata Daroszewska

Public Affairs

Deák

Dr. Veronika Deák

Value & Access Strategy

Domes-Martin

Dr. Katrin Domes-Martin

HTA & Value Demonstration

dos Reis Dias Heller

Alice Elisabeth dos Reis Dias Heller

HTA & Value Demonstration

Euker

Undine Euker

HTA & Value Demonstration

Fackelmann

Gamze Fackelmann

Health Economics & Outcomes Research

Gerbsch

Dr. Norbert Gerbsch

Public Affairs

Gomez Montero

Melissa Gomez Montero

Health Economics & Outcomes Research

Gray

Peter Gray

Statistics & Biometrics

Gujer

Donald Lorenz Gujer

HTA & Value Demonstration

Häussler

Prof. Dr. Bertram Häussler

Chairman of the Board of Management Health Services Research

Hargesheimer

Stefan Hargesheimer

Value & Access Strategy

Henkel

Carl-Christoph Henkel

Clinical Research

Heppt

Dr. Jana Heppt

HTA & Value Demonstration

Hertlein

Juna Hertlein

Value & Access Strategy

Höer

Dr. Ariane Höer

Pharmaceutical Market Research

Holzerny

Dr. Pascale Holzerny

HTA & Value Demonstration

Huebbe

Bennet Huebbe

Value & Access Strategy

Javanbakht

Dr. Mehdi Javanbakht

Director Health Economics & Outcomes Research

Jessel

Sandra Jessel

Public Affairs

Kontogiannis

Vasileios Kontogiannis

Health Economics & Outcomes Research

Kotowa

Wioletta Kotowa

Authorized Signatory Pharma & Biotech

Kulas

Heidi Kulas

Statistics & Biometrics

Kurepkat

Dr. Marc Kurepkat

CEO Clinical Research

Krieger

Julia Isabella Krieger

Value & Access Strategy

Lang

Florentine Lang

HTA & Value Demonstration

Le

Hong Anh Le

Value & Access Strategy

Maag

Lukas Maag

Pharmaceutical Market Research

Mandry

Dr. Tilo Mandry

Lead International Liaison Manager

Manz

Karina Manz

Value & Access Strategy

Mashayekhi

Atefeh Mashayekhi

Health Economics & Outcomes Research

Mathes

Jörg Mathes

HTA & Value Demonstration

Menzner

Dr. Ann-Katrin Menzner

HTA & Value Demonstration

Meyer

Tatjana Meyer

HTA & Value Demonstration

Moïse

Pierre Moïse

Managing Director IGES France Pharma Consulting (IFPC)

Moloney

Eoin Moloney

Health Economics & Outcomes Research

Naal

Santoke Naal

Managing Director IGES UK Pharma Consulting (IUPC)

Naal

Rohan Naal

Market Access UK

Perret

Corinne Perret

HTA & Value Demonstration

Reindl

Stefan Reindl

HTA & Value Demonstration

Ruckdäschel

Dr. Stephan Ruckdäschel

Managing Director HealthEcon | CH

Schiffhorst

Guido Schiffhorst

Director of Statistics & Biometrics

Schlegl-Zanetti

Evelyn Elisabeth Schlegl-Zanetti

HTA & Value Demonstration

Seitz

Dr. Hans-Jürgen Seitz

HTA & Value Demonstration

Steinl

Dr. David Steinl

HTA & Value Demonstration

Sharma

Sakshi Sharma

Health Economics & Outcomes Research

Sussmann

Stephanie Sussmann

Value & Access Strategy

Tran

Thanh Thao Tran

Value & Access Strategy

Uecker

Dr. Silvia Uecker

Clinical Research

van Eerd

Eveline van Eerd

HTA & Value Demonstration

Wolff

Lara Luisa Wolff

Value & Access Strategy

Wolfram

Martha Wolfram

Value & Access Strategy

Ziegler

Dr. Elke Ziegler

HTA & Value Demonstration

Ziemen

Johannes Ziemen

HTA & Value Demonstration

Further Team Members